Lawrence S. Morse

Lawrence S. Morse, MD, PhD, is a distinguished ophthalmologist and clinical researcher who operates a professional corporation specializing in vitreoretinal diseases. Based at the UC Davis Eye Center, he serves as the Director of Retinal Services and is a leading authority on age-related macular degeneration and diabetic retinopathy. His entity functions as a major clinical research site, having participated in over 60 clinical trials for landmark ophthalmic therapies. Dr. Morse collaborates extensively with global pharmaceutical leaders such as Genentech and Regeneron to evaluate novel drug candidates and surgical techniques. His work has been instrumental in the clinical validation of anti-VEGF treatments that have become the standard of care for retinal disorders.